Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion" or "the Company"; 1157.HK), a global leader in ...

U.S. equity dominance exists on a continuum in which perceptions can range from overinflated to underinflated. Click to read.

An important concept promoted by Goheal in recent years is to elevate "liquidity management" to a strategic dimension, and ...

SIGNIFICANT EVENTS DURING 1 JANUARY - 31 MARCH 2025Iconovo and Lonza have entered a collaboration to develop spray-dried formulations of an intranasal biologic drug for Iconovo's proprietary intranasa ...

Q1 2025 Earnings Conference Call May 1, 2025 9:00 AM ETCompany ParticipantsCurt Brooks - Director of IRPierre Brondeau - ...

We expect steady growth until 2028 when patent losses will likely increase ... and high-performance computing applications, which may last decades. Taiwan Semiconductor stock trades 42% below ...

The company’s large size gives it significant competitive advantages in developing new drugs, and its diverse portfolio of drugs helps insulate the company from any one particular patent loss ...

This patent grant enhances RedHill's strategic positioning in the global COVID-19 therapeutic space, a market still expected to be worth more than $3 billion in 2025 [1], and expands its patent ...

In 1994, China joined the Patent Cooperation Treaty under the World Intellectual Property Organization, engaging more deeply ...

China’s National Intellectual Property Administration (CNIPA) released a draft amendment for comment of the Patent ...

The application, numbered PCT/US2025/022598, pertains to the treatment and prevention of hair loss and was confirmed by the U.S. Patent and Trademark Office, acting as the Receiving Office under ...